GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Defence Therapeutics DTC.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.36

+1.43%

Close of 6 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Defence Therapeutics — daily DTC

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Defence Therapeutics on TradingView ↗
Market value
C$20.4m
Last close × shares
Volume
18.2k
Shares, 6 Nov 2026

About Defence Therapeutics

Its shares trade on Canadian Securities Exchange under the ticker DTC.CN. It has been listed since 7 May 2021.

Defence Therapeutics, Inc. engages in the research and development of anti-body drug conjugates. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-05-07. The firm is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological-/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. Its platform's core is the Accum technology, which enables delivery of vaccine antigens or ADCs in their intact form to target cells. The firm is focused on research, development and advancement of various products using its Accum technology, which include Dendritic Cell cancer vaccines using Accum (Accuvac); a new protein-based vaccine formulation against COVID and infectious diseases; ADC targeting various cancers; anti-cancer AccuTOX program; cervical cancer vaccine; mesenchymal stromal cell-based vaccine (ARM) targeting cancer, and messenger ribonucleic acid vaccination.

Figures and description from our data supplier, not checked against the company's own report.

More about Defence Therapeutics →

Latest on Defence Therapeutics

Our reporting

We have not reported on Defence Therapeutics yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Defence Therapeutics's ticker?

Defence Therapeutics trades as DTC.CN on Canadian Securities Exchange, under ISIN CA24463V1013.

What was Defence Therapeutics's last closing price?

0.36 on 6 Nov 2026. The figure is in CAD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.